Dry Eye Center at Southern Eye Associates

The ophthalmologists at Southern Eye Associates treat many patients suffering from Dry Eye Syndrome. In light of what has become an increasing problem, our physicians have chosen to dedicate a portion of our practice to the study and treatment of dry eyes. Our Dry Eye Center helps diagnose patients and create a treatment plan tailored to each patient. Read more about Dry Eye Syndrome and our TearLab below and click here to take our Dry Eye Survey and determine if you may be a candidate to benefit from our Dry Eye Center!

Dry Eyes 2

What is dry eye?  Dry eye is one of the most under-diagnosed ocular diseases, and yet it is the most common reason why patients go see their eye care professional. Your eyes need a constant layer of tears – called the “tear film”- to maintain and protect the ocular surface. In Dry Eye, underlying changes to the health of the tear-producing glands can result in a change in the quantity and quality of the tears you make. This results in a tear film that can no longer provide enough nourishment or protection to the surface of your eye. This can lead to damage of your eye’s surface, which, in turn, can lead to the symptoms of Dry Eye.

What is TearLab?  The TearLab Osmolarity System is an objective and quantitative test for diagnosing and managing Dry Eye patients.  The Osmolarity of your Tear film is a measurement of the salt content in your tears.  The test is fast, easy, and accurate.   An osmolarity number is generated which correlates with a severity scale (normal, mild, moderate, severe) to determine your level of disease.  Essentially, osmolarity gives doctors a meaningful measure of the health and stability of the protective tear film that covers the surface of the eye. This is important for Doctors to know because treatment is customized to the level of severity. TearLab also allows Doctors to measure the success of prescribed treatments.


Glaucoma Study at Southern Eye Associates

Southern Eye has been selected as a host site for research to evaluate a new investigative eye drop for the lowering of intraocular pressure in patients who have glaucoma and ocular hypertension.  The clinical trial is being administered by Innovative Clinical Research, a clinical research company specializing in medical trials. Bausch & Lomb developed the investigational eye drop, Latanoprostene Bunod BOL-303259-X. The study is being performed throughout the U.S. and Europe by leading doctors.

If you are at least 18 years old and have glaucoma or high eye pressure, you may be eligible to participate. Patients are compensated for participating in the study, receive all medications and examinations at no charge, and receive care during the study period by your regular doctor at Southern Eye.  Participation requires approximately 9 visits over a 12 month period.

Southern Eye is excited about being selected as leading doctors to assist in the research and testing of investigational medications that can improve patient care and eyesight.

If you are an existing patient at Southern Eye please ask your doctor for more information, or you may contact Kim Williams at Innovative Clinical Research at (864) 621-3441 or visit their website at www.innovativeclinicalresearch.net.

A full description of this clinical trial is at www.clinicaltrials.gov (search for BOL-303259-X)